What type of study is this?

This is a Animal Study study (also classified as: In Vitro Study).

Pulchinenoside C Attenuates the Development of Osteoarthritis by Inhibiting the PI3K/AKT/NF‐κB Signalling Pathway

View Full Paper

Ask AI

Bookmark

Authors

Experimental evidence suggests pulchinenoside C reduces inflammation and cartilage degeneration in osteoarthritis, indicating therapeutic potential.

Pulchinenoside C significantly inhibits the development of osteoarthritis by downregulating inflammation pathways.
In vitro studies showed that pulchinenoside C reduced matrix metalloproteinase expression in chondrocytes.
In vivo evidence from a C57BL/6 mouse model demonstrated that pulchinenoside C prevented osteoarthritis progression by regulating PI3K/AKT/NF-κB.
These findings highlight the therapeutic promise of pulchinenoside C for osteoarthritis management and inflammation control.

Hu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Experimental evidence suggests pulchinenoside C reduces inflammation and cartilage degeneration in osteoarthritis, indicating therapeutic potential.